Goserelin acetate
CAS No. 145781-92-6
Goserelin acetate( ICI-118630 acetate )
Catalog No. M17309 CAS No. 145781-92-6
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 37 | In Stock |
|
| 5MG | 60 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 294 | In Stock |
|
| 100MG | 442 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGoserelin acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGoserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
-
DescriptionGoserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.(In Vitro):Goserelin (1 nM-1 mM; 48-72 hours) promotes EOC cell apoptosis.Goserelin (100 μM; 24-72 hours) regulates the expression of human apoptosis-related genes in SKOV3-ip cells.Goserelin (100 μM; 24-72 hours) promotes EOC cell apoptosis by upregulating FOXO1 through the PI3K/AKT signaling pathway.(In Vivo):Goserelin (100 μg; s.c.; daily; for 19 days) significantly increases the proportion of apoptotic cells in the subcutaneous xenograft tumors.
-
In VitroApoptosis Analysis Cell Line:SKOV3 cells, SKOV3-ip cells, A2780 cells (human EOC cell lines)Concentration:1 nM, 10 nM, 100 nM, 1 μM, 10 μM, 100 μM, 1 mM Incubation Time:48 hours, 72 hours Result:Significantly increased the total apoptosis rate of SKOV3-ip, SKOV3 and A2780 cells.Western Blot Analysis Cell Line:SKOV3 cells, SKOV3-ip cells, A2780 cells (human EOC cell lines)Concentration:1 nM, 10 nM, 100 nM, 1 μM, 10 μM, 100 μM, 1 mM Incubation Time:48 hours, 72 hours Result:The expression of cleaved-caspase-3 and cleaved-PARP were observably increased at 100 μM.RT-PCR Cell Line:SKOV3-ip cells Concentration:100 μM Incubation Time:24 hours, 48 hours, 72 hours Result:Expression of human apoptosis-related genes regulated
-
In VivoAnimal Model:Five-week-old specific-pathogen free (SPF) female nude mice (18-20 g), subcutaneous xenograft tumor model Dosage:100 μg/mice Administration:Subcutaneous injection, daily, for 19 days Result:Significantly increased the proportion of apoptotic cells in the subcutaneous xenograft tumors
-
SynonymsICI-118630 acetate
-
PathwayOthers
-
TargetOther Targets
-
RecptorGNRHR
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number145781-92-6
-
Formula Weight1329.46
-
Molecular FormulaC61H88N18O16
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 28 mg/mL; 21.06 mM
-
SMILESCC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1.CC(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.I.K. Morton; Judith M. Hall (6 December 2012).?Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp.?136–.
molnova catalog
related products
-
Sacituzumab goviteca...
Sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC) targeting Trop-2, facilitates the delivery of SN-38. It demonstrates anticancer activity .
-
α1 adrenoceptor-MO-1
α1 adrenoceptor-MO-1 (S enantiomer) has affinity at alpha 1 adrenergic receptor with alphalytic activity and analgesic action. It has more active than R enantiomer.
-
Mitoquidone
Mitoquidone, a novel pentacyclic pyrroloquinone, is a potential anticancer agent. Mitoquidone showed good activity in a range of experimental solid tumour models and did not exhibit significant cytotoxicity.
Cart
sales@molnova.com